The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy

AUTOR(ES)

Van Zee, Art

FONTE

American Public Health Association

RESUMO

I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues.

Documentos Relacionados

• OxyContin class-action suit to proceed
• Drug advisory: oxycodone hydrochloride (OxyContin)
• OxyContin-abuse problem appears limited to US
• Promotion of Oral Health in the public and private context
• Iodine, milk, and the elimination of endemic goitre in Britain: the story of an accidental public health triumph.